English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate

MPS-Authors
/persons/resource/persons80410

Krumbholz,  M.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80321

Faber,  H.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80578

Weber,  F.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80414

Kümpfel,  T.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Havla, J., Gerdes, L. A., Meinl, I., Krumbholz, M., Faber, H., Weber, F., et al. (2011). De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology, 258(9), 1665-1669.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8DBA-9
Abstract
There is no abstract available